openPR Logo
Press release

Clinical Trial Technology and Services Market to Reach USD 101.10 Billion by 2034, Growing at a CAGR of 15.3%

05-05-2025 08:39 AM CET | Health & Medicine

Press release from: Polaris Market Research and Consulting

Clinical Trial Technology and Services Market to Reach USD

Clinical Trial Technology and Services Market

The global clinical trial technology and services market is expected to gain market growth during the forecast period of 2025-2034. Polaris Market Research analyses the market to account for USD 101.10 billion by 2034 and is expected to register a CAGR of 15.3% in the above-mentioned forecast period. The market was valued at USD 24.32 billion in 2024.

Get Exclusive Sample Pages of This Report:https://www.polarismarketresearch.com/industry-analysis/clinical-trial-technology-and-services-market/request-for-sample

Market Overview

Technological solutions continue to drive progress in medical research, particularly in the field of clinical trials. Similar to the influences it has had on everyday lives, digital technology has notably transformed the medical research landscape. The introduction of new technologies in clinical trials have impacted in several ways, including changes in research methodologies and the ways treatments are delivered.

Well-designed and controlled clinical trials serve as a criterion for establishing evidence in medical research. But traditional approaches often face significant challenges. Rapid technological advancement offers inventive solutions for many of these challenges, thus reshaping the clinical trials landscape. For example, electronic data capture (EDC) initiates digitizing data entry, enables researchers to garner, authenticate, and handle data electronically.

Market Drivers

Growing Complexity of Clinical Trials: Developing study designs, stringent regulatory requirements, and the rise of precision medicine are driving the need for more advanced solutions. For example, a May 2021 report from Tufts CSDD revealed that oncology trials, driven by innovative designs, a global scope, and targeted patient subpopulations, face longer durations, increased data requirements, and more protocol changes. These challenges are escalating implementation difficulties, despite the fact that faster regulatory reviews are contributing to the growth of the clinical trial technology and services market.

Rising Adoption of Digital Health Technologies: The adoption of digital health technologies is a prominent driver boosting the market share as the industry moves towards patient-concentrated and decentralized clinical trials (DCT). For instance, in November 2023, AstraZeneca introduced Evinova, a digital health solution provide supported by AstraZeneca, Parexel, and Fortrea.

Request for a Discount on this Report Before Purchase: https://www.polarismarketresearch.com/industry-analysis/clinical-trial-technology-and-services-market/request-for-discount-pricing

Key Market Players

Market competition is moderate. The key strategies used by competitors to establish and expand their presence in the market include collaborations, partnerships, and market expansion. The top players in the market are:

Allscripts Healthcare LLC
Aris Global LLC
Clinevo Technologies
Cognizant
DATATRAK International, Inc.
Ennov
IBM
IQVIA, Inc.
Koninklijke Philips N.V.
MasterControl Solutions, Inc.
Medidata (Dassault Systèmes)
Optum Inc.
Oracle
Veeva Systems

Segment Categorization

The report includes the segmentation of the clinical trial technology and services market based on technology solutions, phases, end use, and region. Based on technology solutions, the solutions segment dominated the market in 2024 due to the growing adoption of progressive digital platforms outlined to improve trial efficiency, data handling, and regulatory conformity.

Based on phases, the phase I segment is projected to witness the fastest growth owing to a growing aggregate of early clinical trials and the surging requirement for inventive technology solutions to enhance study design and implementation.

Quick Buy @ https://www.polarismarketresearch.com/buy/4509/0

Regional Overview

The clinical trial technology and services market is analyzed across various regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America led the market in terms of revenue in 2024, driven by a robust biopharmaceutical industry, strong regulatory frameworks, and significant investments in clinical research.

For example, in October 2023, HCA Healthcare and GRAIL partnered to introduce GRAIL's Galleri multi-cancer early detection (MCED) test at select HCA practices. This innovative blood test can detect over 50 types of cancers, aiming to improve early detection and ultimately reduce cancer mortality rates. North America also hosts numerous leading pharmaceutical companies, contract research organizations (CROs), and technology providers, which play a crucial role in fostering innovation and accelerating the adoption of advanced clinical trial solutions.

The region benefits from favorable regulatory policies, including expedited approval processes and initiatives promoting the adoption of digital trials. The growing emphasis on decentralized clinical trials, precision medicine, and the integration of AI-driven analytics further bolsters North America's dominant position in the clinical trial technology and services market. This makes the region a key hub for research and development activities, ensuring its leadership in advancing clinical trials worldwide.

More Trending Latest Reports by Polaris Market Research:

https://www.polarismarketresearch.com/industry-analysis/high-resolution-melting-analysis-market
https://www.polarismarketresearch.com/industry-analysis/digital-health-coaching-market
https://www.polarismarketresearch.com/industry-analysis/modified-atmosphere-packaging-market
https://www.polarismarketresearch.com/industry-analysis/brain-computer-interface-gaming-market
https://www.polarismarketresearch.com/industry-analysis/edge-computing-infrastructure-security-solutions-market
https://www.polarismarketresearch.com/industry-analysis/animal-feed-acidifiers-market
https://www.polarismarketresearch.com/industry-analysis/ophthalmic-spectacle-lenses-and-equipment-market
https://www.polarismarketresearch.com/industry-analysis/japan-cancer-vaccines-market
https://www.polarismarketresearch.com/industry-analysis/compound-semiconductor-market
https://www.polarismarketresearch.com/industry-analysis/dendritic-cell-cancer-vaccine-market

Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Clinical Trial Technology and Services Market to Reach USD 101.10 Billion by 2034, Growing at a CAGR of 15.3% here

News-ID: 3998620 • Views:

More Releases from Polaris Market Research and Consulting

In Situ Hybridization Market Size Set to Hit USD 3,015.57 Million by 2034, Growing at a CAGR of 6.9%
In Situ Hybridization Market Size Set to Hit USD 3,015.57 Million by 2034, Growi …
Polaris Market Research has released new insights into the In Situ Hybridization market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors. Market at a Glance In 2024, the market was valued at USD 1,546.93 million and is anticipated to grow to USD 3,015.57 million by
Next Generation Sequencing Sample Preparation Market Size Set to Hit USD 16.57 Billion by 2034, Growing at a CAGR of 15.02%
Next Generation Sequencing Sample Preparation Market Size Set to Hit USD 16.57 B …
Polaris Market Research has released new insights into the Next Generation Sequencing Sample Preparation market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors. Market at a Glance In 2024, the market was valued at USD 4.09 billion and is anticipated to grow to USD 16.57
Plastic Welding Equipment Market Projected to Reach USD 2.69 Billion by 2034 , Registering a CAGR of 5.38%
Plastic Welding Equipment Market Projected to Reach USD 2.69 Billion by 2034 , R …
Polaris Market Research announces the release of its latest study on the Plastic Welding Equipment market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at USD 1.60 billion in 2024 and is expected to reach USD
DNA Manufacturing Market Projected to Reach USD 21.82 Billion by 2034, Registering a CAGR of 14.62%
DNA Manufacturing Market Projected to Reach USD 21.82 Billion by 2034, Registeri …
Polaris Market Research announces the release of its latest study on the DNA Manufacturing market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at USD 5.59 billion in 2024 and is expected to reach USD 21.82

All 5 Releases


More Releases for Clinical

Miami Clinical Research Sets the Standard for Clinical Trials
Miami Clinical Research, a frontrunner in the world of clinical trials and medical research, has emerged as the prime choice for global corporate pharmaceutical giants. With a deep understanding of the complexities of medical studies, the organization champions the crucial role of research in the evolution of transformative therapeutic interventions. Miami, FL - Renowned as a first-rate center for professional medical exploration, Miami Clinical Research [https://miamiclinicalresearch.com] boasts state-of-the-art facilities, advanced technologies,
E-Clinical Solutions Market: Revolutionizing Healthcare and Clinical Trials
Introduction The e-Clinical solutions market has become a pivotal component of the healthcare and pharmaceutical industries. E-Clinical solutions refer to a set of software, tools, and platforms designed to streamline clinical trials and healthcare management. These solutions include electronic data capture (EDC), clinical trial management systems (CTMS), laboratory information management systems (LIMS), and other integrated tools that improve the efficiency, accuracy, and speed of clinical trials and healthcare services. The primary
E-Clinical Solutions Market: Revolutionizing Clinical Trials
The e-clinical solutions market has experienced significant growth in recent years, driven by the increasing complexity of clinical trials and the need for efficient, accurate, and compliant data management. E-clinical solutions provide a comprehensive suite of tools and technologies to streamline clinical trial processes, accelerate drug development, and improve patient outcomes. Market Size and Growth The global e-clinical solutions market is estimated to be worth billions of dollars, with a significant portion
Clinical Trials Management System Market Optimizing Clinical Trials: The Crucial …
Clinical Trials Management System Market to reach over USD 5.06 billion by the year 2031- Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Clinical Trials Management System Market Size, Share & Trends Analysis Report By Solution Type (Enterprise and Site based), By Delivery Mode (Web & Cloud-based, On-premise), By Component (Software, Services), By End-user (Pharmaceutical and Biotechnology Firms, Medical
Clinical Research and Clinical Trials Summit
Clinical Research 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation. This is the premier interdisciplinary forum for
E-Clinical Trial Solutions Market To Accelerating Clinical Development Technolog …
The study of the "Global e-Clinical Trial Solutions Market" provides the market size information and market trends along with the factors and parameters impacting it in both short and long term. The study ensures a 360° view, bringing out the complete key insights of the industry. The Global e-Clinical Trial Solutions Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the e-Clinical